ZEVTERA
Live / Applied — Statement of use — registration review complete (as of 01 Apr 2026)
What this means for you
Not registered yet, but its 27 Jul 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90849714
- Mark type
- Stylized text
- Filed
- 27 Jul 2021
- Published for opposition
- 27 Dec 2022
- Attorney of record
- Evan A. Raynes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of infectious diseases, dermatological disorders, cardiovascular diseases
Owner
- BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL, ALLSCHWIL, CH
- Basilea Pharmaceutica International Ltd., Basel, CH
- Basilea Pharmaceutica International Ltd., Basel, CH
Prosecution history
- 01 Apr 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Apr 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Sept 2025 — USE AMENDMENT FILED
- 27 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 26 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Sept 2025 — SOU EXTENSION 5 GRANTED
- 18 Aug 2025 — SOU EXTENSION 5 FILED
- 18 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2025 — SOU EXTENSION 4 GRANTED
- 13 Feb 2025 — SOU EXTENSION 4 FILED
- 12 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED